Magellan Health Services (MGLN) 56.48 $MGLN
Magellan Rx Management's Fourth Annual Medical Pharmacy Trend Report Reveals Opportunities for Payors to Better Manage Care, Reduce Costs
Business Wire - Wed May 07, 9:43AM CDT
Magellan Rx Management, a division of Magellan Health Services, Inc. (NASDAQ: MGLN), today released its fourth annual Medical Pharmacy Trend Report, the only industry benchmark of its kind to analyze high cost injectable drugs paid under the medical benefit, including those drugs used to treat complex conditions such as cancer, rheumatoid arthritis and multiple sclerosis. The fourth edition of the report includes trends for the past three years, including this year's responses from 48 individual health plans that collectively manage 166 million lives.
NIA Magellan Launches Animated Website to Assist Parents in Preparing Their Children for CT Scans, MRI Scans, X-Rays
Business Wire - Thu May 01, 12:50PM CDT
NIA Magellan, a subsidiary of Magellan Health Services, Inc. (NASDAQ: MGLN), recently launched "RadZone Kids," an easy-to-use community resource to assist parents and caregivers in preparing their children for various diagnostic imaging tests, including CT scans, MRI scans and X-rays.
Reported and Upcoming Financial Results, Upcoming Conference Participations, and US FDA Approval - Analyst Notes on AMAG, Insys Therapeutics, Cayman, Lannett and Magellan Health Services
PR Newswire - Tue Apr 29, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), Insys Therapeutics, Inc. (NASDAQ: INSY), WuXi PharmaTech (Cayman) Inc. (NYSE: WX), Lannett Company, Inc. (NYSE: LCI) and Magellan Health Services Inc. (NASDAQ: MGLN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1741-100free.
Magellan Health Services Reports First Quarter 2014 Financial Results
Business Wire - Tue Apr 29, 5:31AM CDT
Magellan Health Services, Inc. (NASDAQ: MGLN) today reported financial results for the first quarter 2014, as summarized below. For the quarter ended March 31, 2014, the company reported net revenue of $966.5 million, segment profit of $76.5 million, and net income of $25.7 million, or $0.92 earnings per share (EPS). Segment profit is equal to net revenues less the sum of cost of care, cost of goods sold, direct service costs and other operating expenses, and includes income from unconsolidated subsidiaries, but excludes segment profit (loss) from non-controlling interests held by other parties, as well as stock compensation expense.
Magellan Health Services to Present at Two Upcoming Healthcare Conferences
Business Wire - Thu Apr 24, 1:30PM CDT
Magellan Health Services Inc. (NASDAQ: MGLN) announced today that members of its executive team will present at two upcoming healthcare conferences.
Magellan Health Services to Hold Investor Day in New York City
Business Wire - Thu Apr 24, 10:53AM CDT
Magellan Health Services Inc. (NASDAQ: MGLN) today announced that it will host an Investor Day in New York City from 8:30 a.m. until approximately 2:30 p.m. Eastern time on Tuesday, June 17, 2014. The meeting will feature presentations by Magellan's executive management team highlighting the company's business strategy to deliver long-term growth and enhance shareholder value, including specifics related to its various businesses.
Magellan Health (MGLN): Moving Average Crossover Spotted - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 9:38AM CDT
Magellan Health (MGLN): Moving Average Crossover Spotted
Interim Clinical Study Results, Leadership Appointments, and Earnings Release Schedules - Analyst Notes on Merck, Magellan, ABIOMED, CONMED, and Greatbatch
PR Newswire - Tue Apr 15, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Merck & Co., Inc. (NYSE: MRK), Magellan Health Services Inc. (NASDAQ: MGLN), ABIOMED, Inc. (NASDAQ: ABMD), CONMED Corporation (NASDAQ: CNMD), and Greatbatch, Inc. (NYSE: GB). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1143-100free
Immune Pharmaceuticals Announces Company Highlights and Reports Full Fiscal Year 2013 Financial Results
GlobeNewswire - Thu Apr 10, 1:30AM CDT
Immune Pharmaceuticals Inc. (OTCQX:IMNP) and (Nasdaq:IMNP) ("Immune" or "the Company"
announced today company highlights and its financial results for the 12-month period ended December 31, 2013.
Magellan Health Services Opens Toll-Free Number Following Stabbing at Franklin Regional High School in Murrysville, Pa.
Business Wire - Wed Apr 09, 5:00PM CDT
Magellan Health Services (NASDAQ: MGLN) today announced that, in response to the stabbing at Franklin Regional High School in Murrysville, Pa., it has set up a 24-hour toll-free hotline for individuals to access, regardless of whether or not they are Magellan members.
Magellan Health Services Announces Daniel M. Parietti as CEO of AlphaCare
Business Wire - Mon Apr 07, 9:02AM CDT
Magellan Health Services Inc. (NASDAQ: MGLN) today announced that Daniel M. Parietti has been selected as the chief executive officer of AlphaCare, a Medicaid Managed Long Term Care HMO and Medicare Plan focused on serving the unique needs of New York's long-term care and dual eligible populations. Parietti, who begins today, will report to Scott Markovich, president of Magellan Complete Care, which provides integrated programs across all aspects of specialty healthcare, including complex care management for special populations. In December, Magellan completed its strategic investment in AlphaCare, and now owns 65 percent of the company.
Health Care Executive Dr. Rene Lerer Appointed President Of Guidewell Group Of Companies
PR Newswire - Wed Apr 02, 9:49AM CDT
Rene Lerer, M.D., has been appointed President of Florida Blue and the GuideWell group of companies which includes GuideWell Health, GuideWell Connect and Diversified Service Options, Inc. Lerer will report to Chairman and Chief Executive Officer Patrick J. Geraghty as part of the newly created Office of the CEO.
Magellan Health Services to Acquire CDMI
Business Wire - Tue Apr 01, 5:30AM CDT
Magellan Health Services, Inc. (NASDAQ:MGLN) today announced that it has entered into an agreement to acquire CDMI, LLC, a privately-held company that provides a range of clinical consulting programs and negotiates and administers drug rebates for managed care organizations (MCO) and other customers. Headquartered in Newport, R.I., and founded in 2009 by experienced pharmacy executives, CDMI has established strong relationships with MCOs and drug manufacturers. CDMI works with over 30 health plans, and in 2013 had net revenues of approximately $43 million, primarily derived from rebate management.
Magellan Health Services Chooses Casenet to Support Magellan Complete Care
PRWeb - Tue Mar 25, 3:52AM CDT
Casenet, LLC, a leading provider of extensible care management solutions, today announced that Magellan Health Services, Inc. has selected and implemented Casenet(R) TruCare(R) to support its growing Magellan Complete Care of Florida business. With TruCare, Magellan Complete Care has enhanced its technological capabilities to help manage the healthcare needs of its members.
Healthcare Companies Report Acquisitions, Upcoming Results Schedules, Dividends, and Annual Reviews - Analyst Notes on Pfizer, Magellan Health Services, Prothena, Alere, and KYTHERA
PR Newswire - Fri Mar 21, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Pfizer Inc. (NYSE: PFE), Magellan Health Services Inc. (NASDAQ: MGLN), Prothena Corporation plc (NASDAQ: PRTA), Alere Inc. (NYSE: ALR), and KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Magellan Rx Management Launches Audit Tool to Help Determine PBM Effectiveness
Business Wire - Thu Mar 20, 8:59AM CDT
Magellan Rx Management, a division of Magellan Health Services, Inc. (NASDAQ: MGLN), today announced the launch of MRxAudit, a comprehensive tool to help determine the effectiveness of pharmacy benefit management (PBM) services. The tool is being offered on a complimentary basis for a limited time, to help groups gauge the effectiveness of their current PBM.
Magellan Health Services Announces First Quarter 2014 Earnings Conference Call
Business Wire - Fri Mar 14, 10:22AM CDT
Magellan Health Services Inc. (NASDAQ: MGLN) today announced that it will release first quarter 2014 earnings results on Tuesday, April 29, 2014. Management will discuss the company's financial results, as well as its business strategy and outlook, in a conference call to be held the same day from 11:00 a.m. to noon Eastern.
Earnings Miss but Revs Beat at Magellan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 8:55AM CST
Magellan Health reported fourth-quarter 2013 operating net income of 67 cents per share, missing the Zacks Consensus Estimate of 87 cents by 19.3%.
Magellan Health Services Reports Fourth Quarter and Full Year 2013 Financial Results
Business Wire - Mon Mar 03, 5:30AM CST
Magellan Health Services, Inc. (NASDAQ:MGLN) today reported financial results for the fourth quarter and full year 2013, as summarized below. For the year ended December 31, 2013, the company reported net revenue of $3.5 billion, segment profit of $259.4 million, and net income of $125.3 million, or $4.53 per diluted common share. Segment profit is equal to net revenues less the sum of cost of care, cost of goods sold, direct service costs and other operating expenses, and includes income from unconsolidated subsidiaries, but excludes income from non-controlling interests held by other parties, as well as stock compensation expense.
NASHO Announces Fifth Annual Most Influential In Specialty Health Award
PR Newswire - Thu Feb 27, 12:31PM CST
The National Association of Specialty Health Organizations (NASHO) today announced that nominations are now being accepted for its fifth annual Most Influential in Specialty Health Award. The award recognizes leaders in specialty health who have played a major role in advancing the industry's mission to improve value, access and availability of high-quality specialty health services. Previous honorees include 2010 inaugural recipient, George DeVries, III, co-founder of American Specialty Health; followed by Rob Lynch, President and CEO of VSP Global(SM); Karen Rohan, past President of Magellan Health Services; and last year's recipient, Cherrill Farnsworth, President & CEO of HealthHelp®.
Magellan Rx Management's Fourth Annual Medical Pharmacy Trend Report Reveals Opportunities for Payors to Better Manage Care, Reduce Costs
Business Wire - Wed May 07, 9:43AM CDT
Magellan Rx Management, a division of Magellan Health Services, Inc. (NASDAQ: MGLN), today released its fourth annual Medical Pharmacy Trend Report, the only industry benchmark of its kind to analyze high cost injectable drugs paid under the medical benefit, including those drugs used to treat complex conditions such as cancer, rheumatoid arthritis and multiple sclerosis. The fourth edition of the report includes trends for the past three years, including this year's responses from 48 individual health plans that collectively manage 166 million lives.
NIA Magellan Launches Animated Website to Assist Parents in Preparing Their Children for CT Scans, MRI Scans, X-Rays
Business Wire - Thu May 01, 12:50PM CDT
NIA Magellan, a subsidiary of Magellan Health Services, Inc. (NASDAQ: MGLN), recently launched "RadZone Kids," an easy-to-use community resource to assist parents and caregivers in preparing their children for various diagnostic imaging tests, including CT scans, MRI scans and X-rays.
Reported and Upcoming Financial Results, Upcoming Conference Participations, and US FDA Approval - Analyst Notes on AMAG, Insys Therapeutics, Cayman, Lannett and Magellan Health Services
PR Newswire - Tue Apr 29, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), Insys Therapeutics, Inc. (NASDAQ: INSY), WuXi PharmaTech (Cayman) Inc. (NYSE: WX), Lannett Company, Inc. (NYSE: LCI) and Magellan Health Services Inc. (NASDAQ: MGLN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1741-100free.
Magellan Health Services Reports First Quarter 2014 Financial Results
Business Wire - Tue Apr 29, 5:31AM CDT
Magellan Health Services, Inc. (NASDAQ: MGLN) today reported financial results for the first quarter 2014, as summarized below. For the quarter ended March 31, 2014, the company reported net revenue of $966.5 million, segment profit of $76.5 million, and net income of $25.7 million, or $0.92 earnings per share (EPS). Segment profit is equal to net revenues less the sum of cost of care, cost of goods sold, direct service costs and other operating expenses, and includes income from unconsolidated subsidiaries, but excludes segment profit (loss) from non-controlling interests held by other parties, as well as stock compensation expense.
Magellan Health Services to Present at Two Upcoming Healthcare Conferences
Business Wire - Thu Apr 24, 1:30PM CDT
Magellan Health Services Inc. (NASDAQ: MGLN) announced today that members of its executive team will present at two upcoming healthcare conferences.
Magellan Health Services to Hold Investor Day in New York City
Business Wire - Thu Apr 24, 10:53AM CDT
Magellan Health Services Inc. (NASDAQ: MGLN) today announced that it will host an Investor Day in New York City from 8:30 a.m. until approximately 2:30 p.m. Eastern time on Tuesday, June 17, 2014. The meeting will feature presentations by Magellan's executive management team highlighting the company's business strategy to deliver long-term growth and enhance shareholder value, including specifics related to its various businesses.
Magellan Health (MGLN): Moving Average Crossover Spotted - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 9:38AM CDT
Magellan Health (MGLN): Moving Average Crossover Spotted
Interim Clinical Study Results, Leadership Appointments, and Earnings Release Schedules - Analyst Notes on Merck, Magellan, ABIOMED, CONMED, and Greatbatch
PR Newswire - Tue Apr 15, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Merck & Co., Inc. (NYSE: MRK), Magellan Health Services Inc. (NASDAQ: MGLN), ABIOMED, Inc. (NASDAQ: ABMD), CONMED Corporation (NASDAQ: CNMD), and Greatbatch, Inc. (NYSE: GB). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1143-100free
Immune Pharmaceuticals Announces Company Highlights and Reports Full Fiscal Year 2013 Financial Results
GlobeNewswire - Thu Apr 10, 1:30AM CDT
Immune Pharmaceuticals Inc. (OTCQX:IMNP) and (Nasdaq:IMNP) ("Immune" or "the Company"
announced today company highlights and its financial results for the 12-month period ended December 31, 2013. Magellan Health Services Opens Toll-Free Number Following Stabbing at Franklin Regional High School in Murrysville, Pa.
Business Wire - Wed Apr 09, 5:00PM CDT
Magellan Health Services (NASDAQ: MGLN) today announced that, in response to the stabbing at Franklin Regional High School in Murrysville, Pa., it has set up a 24-hour toll-free hotline for individuals to access, regardless of whether or not they are Magellan members.
Magellan Health Services Announces Daniel M. Parietti as CEO of AlphaCare
Business Wire - Mon Apr 07, 9:02AM CDT
Magellan Health Services Inc. (NASDAQ: MGLN) today announced that Daniel M. Parietti has been selected as the chief executive officer of AlphaCare, a Medicaid Managed Long Term Care HMO and Medicare Plan focused on serving the unique needs of New York's long-term care and dual eligible populations. Parietti, who begins today, will report to Scott Markovich, president of Magellan Complete Care, which provides integrated programs across all aspects of specialty healthcare, including complex care management for special populations. In December, Magellan completed its strategic investment in AlphaCare, and now owns 65 percent of the company.
Health Care Executive Dr. Rene Lerer Appointed President Of Guidewell Group Of Companies
PR Newswire - Wed Apr 02, 9:49AM CDT
Rene Lerer, M.D., has been appointed President of Florida Blue and the GuideWell group of companies which includes GuideWell Health, GuideWell Connect and Diversified Service Options, Inc. Lerer will report to Chairman and Chief Executive Officer Patrick J. Geraghty as part of the newly created Office of the CEO.
Magellan Health Services to Acquire CDMI
Business Wire - Tue Apr 01, 5:30AM CDT
Magellan Health Services, Inc. (NASDAQ:MGLN) today announced that it has entered into an agreement to acquire CDMI, LLC, a privately-held company that provides a range of clinical consulting programs and negotiates and administers drug rebates for managed care organizations (MCO) and other customers. Headquartered in Newport, R.I., and founded in 2009 by experienced pharmacy executives, CDMI has established strong relationships with MCOs and drug manufacturers. CDMI works with over 30 health plans, and in 2013 had net revenues of approximately $43 million, primarily derived from rebate management.
Magellan Health Services Chooses Casenet to Support Magellan Complete Care
PRWeb - Tue Mar 25, 3:52AM CDT
Casenet, LLC, a leading provider of extensible care management solutions, today announced that Magellan Health Services, Inc. has selected and implemented Casenet(R) TruCare(R) to support its growing Magellan Complete Care of Florida business. With TruCare, Magellan Complete Care has enhanced its technological capabilities to help manage the healthcare needs of its members.
Healthcare Companies Report Acquisitions, Upcoming Results Schedules, Dividends, and Annual Reviews - Analyst Notes on Pfizer, Magellan Health Services, Prothena, Alere, and KYTHERA
PR Newswire - Fri Mar 21, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Pfizer Inc. (NYSE: PFE), Magellan Health Services Inc. (NASDAQ: MGLN), Prothena Corporation plc (NASDAQ: PRTA), Alere Inc. (NYSE: ALR), and KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Magellan Rx Management Launches Audit Tool to Help Determine PBM Effectiveness
Business Wire - Thu Mar 20, 8:59AM CDT
Magellan Rx Management, a division of Magellan Health Services, Inc. (NASDAQ: MGLN), today announced the launch of MRxAudit, a comprehensive tool to help determine the effectiveness of pharmacy benefit management (PBM) services. The tool is being offered on a complimentary basis for a limited time, to help groups gauge the effectiveness of their current PBM.
Magellan Health Services Announces First Quarter 2014 Earnings Conference Call
Business Wire - Fri Mar 14, 10:22AM CDT
Magellan Health Services Inc. (NASDAQ: MGLN) today announced that it will release first quarter 2014 earnings results on Tuesday, April 29, 2014. Management will discuss the company's financial results, as well as its business strategy and outlook, in a conference call to be held the same day from 11:00 a.m. to noon Eastern.
Earnings Miss but Revs Beat at Magellan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 8:55AM CST
Magellan Health reported fourth-quarter 2013 operating net income of 67 cents per share, missing the Zacks Consensus Estimate of 87 cents by 19.3%.
Magellan Health Services Reports Fourth Quarter and Full Year 2013 Financial Results
Business Wire - Mon Mar 03, 5:30AM CST
Magellan Health Services, Inc. (NASDAQ:MGLN) today reported financial results for the fourth quarter and full year 2013, as summarized below. For the year ended December 31, 2013, the company reported net revenue of $3.5 billion, segment profit of $259.4 million, and net income of $125.3 million, or $4.53 per diluted common share. Segment profit is equal to net revenues less the sum of cost of care, cost of goods sold, direct service costs and other operating expenses, and includes income from unconsolidated subsidiaries, but excludes income from non-controlling interests held by other parties, as well as stock compensation expense.
NASHO Announces Fifth Annual Most Influential In Specialty Health Award
PR Newswire - Thu Feb 27, 12:31PM CST
The National Association of Specialty Health Organizations (NASHO) today announced that nominations are now being accepted for its fifth annual Most Influential in Specialty Health Award. The award recognizes leaders in specialty health who have played a major role in advancing the industry's mission to improve value, access and availability of high-quality specialty health services. Previous honorees include 2010 inaugural recipient, George DeVries, III, co-founder of American Specialty Health; followed by Rob Lynch, President and CEO of VSP Global(SM); Karen Rohan, past President of Magellan Health Services; and last year's recipient, Cherrill Farnsworth, President & CEO of HealthHelp®.
